NY-ESO-1–specific T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NY-ESO-1–specific T cells, covering 2016-02-03 to 2017-07-05. Get the full timeline:
Most recent: Clinical Trial Update: NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving Palliative Radiation Therapy [Phase 1]